Drug Profile
EG 011
Alternative Names: Ad-VEGF-D; EG011; VEGF-D short-formLatest Information Update: 23 Nov 2012
Price :
$50
*
At a glance
- Originator Ark Therapeutics
- Class Gene therapies; Ischaemic heart disorder therapies
- Mechanism of Action Gene transference; Vascular endothelial growth factor D stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Angina pectoris